Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06917586 · ClinicalTrials.gov registry record

Mosaic Mitral Valve: Long-Term Outcomes in Patients Under 65

A clinical trial of Valve Disease, Heart and Valve Replacement, sponsored by Michael Moront.

Recruiting
Registry status
300
Enrollment target
1
Study location

NCT06917586 is a study of Valve Disease, Heart and Valve Replacement that is actively recruiting participants, run by Michael Moront. The registered enrollment target is 300 participants, below the 671-participant average among 5 other Valve Disease, Heart trials with a reported enrollment target (55% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06917586, a study of Valve Disease, Heart and Valve Replacement, is actively recruiting participants, sponsored by Michael Moront.

RECRUITING
Registry status
300 participants
Enrollment target
1
Study location

Study Summary

The safety and efficacy of the Mosaic bioprosthetic heart valves for cardiac valve replacement in the aortic position has been well documented throughout the literature. However, few studies assessing structural valve deficiency, patient outcomes and overall product performance in patients under the age of 65 exists for the Mosaic mitral valve bioprosthetic. This study aims to assess valve efficacy, stability, and post operative outcomes in patients who have received the Mosaic mitral valve prothesis at ProMedica Toledo Hospital and were under the age of 65.

Study Locations (1)

Ohio

  • ProMedica Toledo Hospital - Toledo

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2025-01-01
Est. Completion 2027-07-01

Sponsor

Michael Moront

1 total trials

What the Registry Record Tells You About NCT06917586

The ClinicalTrials.gov registry entry for NCT06917586 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 671-participant average among 5 other Valve Disease, Heart trials with a reported enrollment target (55% lower). The listed sponsor is Michael Moront, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Valve Disease, Heart appearing as the primary indexed condition, and to 0 interventions.

NCT06917586 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT06917586 about?

NCT06917586 is a clinical study titled "Mosaic Mitral Valve: Long-Term Outcomes in Patients Under 65". The safety and efficacy of the Mosaic bioprosthetic heart valves for cardiac valve replacement in the aortic position has been well documented throughout the literature. However, few studies assessing structural valve deficiency, patient outcomes and overall product performance in patients under the...

What is the current status of trial NCT06917586?

This trial is currently recruiting. The enrollment target is 300 participants. The study started on 2025-01-01. Estimated completion is 2027-07-01.

What conditions does trial NCT06917586 study?

This clinical trial studies the following conditions: Valve Disease, Heart, Valve Replacement, Valve Regurgitation, Mitral, Valve Heart Stenosis.

Who is sponsoring clinical trial NCT06917586?

This trial is sponsored by Michael Moront, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06917586 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Valve Disease, Heart

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.